MedPath

MOTI LAL NEHRU MEDICAL COLLEGE

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:2

Trial Phases

2 Phases

Phase 3:2
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (50.0%)
Phase 3
2 (50.0%)

Randomized Controlled Trial of Rectal Indomethacin Versus Combined Pancreatic Stent Placement and Rectal Indomethacin for Preventing Post-ERCP Pancreatitis

Not Applicable
Recruiting
Conditions
Post-ERCP Acute Pancreatitis
Interventions
Procedure: Prophylactic Pancreatic duct stenting
First Posted Date
2023-05-12
Last Posted Date
2023-06-28
Lead Sponsor
Moti Lal Nehru Medical College
Target Recruit Count
384
Registration Number
NCT05857514
Locations
🇮🇳

Department of Gastroenterology and Hepatology, MLN Medical college and SRN Hospital, Allahābād, Uttar Pradesh, India

🇮🇳

Department of Gastroenterology and Hepatology, Allahābād, Uttar Pradesh, India

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.